These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 21865316)

  • 1. A critical role for macrophages in neovessel formation and the development of stenosis in tissue-engineered vascular grafts.
    Hibino N; Yi T; Duncan DR; Rathore A; Dean E; Naito Y; Dardik A; Kyriakides T; Madri J; Pober JS; Shinoka T; Breuer CK
    FASEB J; 2011 Dec; 25(12):4253-63. PubMed ID: 21865316
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Zoledronate alters natural progression of tissue-engineered vascular grafts.
    Chang YC; Li J; Mirhaidari G; Zbinden J; Barker J; Blum K; Reinhardt J; Best C; Kelly J; Shoji T; Yi T; Breuer C
    FASEB J; 2021 Oct; 35(10):e21849. PubMed ID: 34473380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of Bone Marrow Mononuclear Cell Seeding for Nanofiber Vascular Grafts.
    Fukunishi T; Best CA; Ong CS; Groehl T; Reinhardt J; Yi T; Miyachi H; Zhang H; Shinoka T; Breuer CK; Johnson J; Hibino N
    Tissue Eng Part A; 2018 Jan; 24(1-2):135-144. PubMed ID: 28486019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TGF-β receptor 1 inhibition prevents stenosis of tissue-engineered vascular grafts by reducing host mononuclear phagocyte activation.
    Lee YU; de Dios Ruiz-Rosado J; Mahler N; Best CA; Tara S; Yi T; Shoji T; Sugiura T; Lee AY; Robledo-Avila F; Hibino N; Pober JS; Shinoka T; Partida-Sanchez S; Breuer CK
    FASEB J; 2016 Jul; 30(7):2627-36. PubMed ID: 27059717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tissue-Engineered Small Diameter Arterial Vascular Grafts from Cell-Free Nanofiber PCL/Chitosan Scaffolds in a Sheep Model.
    Fukunishi T; Best CA; Sugiura T; Shoji T; Yi T; Udelsman B; Ohst D; Ong CS; Zhang H; Shinoka T; Breuer CK; Johnson J; Hibino N
    PLoS One; 2016; 11(7):e0158555. PubMed ID: 27467821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential outcomes of venous and arterial tissue engineered vascular grafts highlight the importance of coupling long-term implantation studies with computational modeling.
    Best CA; Szafron JM; Rocco KA; Zbinden J; Dean EW; Maxfield MW; Kurobe H; Tara S; Bagi PS; Udelsman BV; Khosravi R; Yi T; Shinoka T; Humphrey JD; Breuer CK
    Acta Biomater; 2019 Aug; 94():183-194. PubMed ID: 31200116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiotensin II receptor I blockade prevents stenosis of tissue engineered vascular grafts.
    Ruiz-Rosado JD; Lee YU; Mahler N; Yi T; Robledo-Avila F; Martinez-Saucedo D; Lee AY; Shoji T; Heuer E; Yates AR; Pober JS; Shinoka T; Partida-Sanchez S; Breuer CK
    FASEB J; 2018 Jun; 32(12):fj201800458. PubMed ID: 29906242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Magnetic Resonance Imaging of Shear Stress and Wall Thickness in Tissue-Engineered Vascular Grafts.
    Stacy MR; Best CA; Maxfield MW; Qiu M; Naito Y; Kurobe H; Mahler N; Rocco KA; Sinusas AJ; Shinoka T; Sampath S; Breuer CK
    Tissue Eng Part C Methods; 2018 Aug; 24(8):465-473. PubMed ID: 29978768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preclinical study of patient-specific cell-free nanofiber tissue-engineered vascular grafts using 3-dimensional printing in a sheep model.
    Fukunishi T; Best CA; Sugiura T; Opfermann J; Ong CS; Shinoka T; Breuer CK; Krieger A; Johnson J; Hibino N
    J Thorac Cardiovasc Surg; 2017 Apr; 153(4):924-932. PubMed ID: 27938900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tissue-engineered vascular grafts: does cell seeding matter?
    Mirensky TL; Hibino N; Sawh-Martinez RF; Yi T; Villalona G; Shinoka T; Breuer CK
    J Pediatr Surg; 2010 Jun; 45(6):1299-305. PubMed ID: 20620335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of evolving biomechanical properties of tissue engineered vascular grafts in the arterial circulation.
    Udelsman BV; Khosravi R; Miller KS; Dean EW; Bersi MR; Rocco K; Yi T; Humphrey JD; Breuer CK
    J Biomech; 2014 Jun; 47(9):2070-9. PubMed ID: 24702863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tissue Engineered Vascular Graft Recipient Interleukin 10 Status Is Critical for Preventing Thrombosis.
    Mirhaidari GJM; Barker JC; Zbinden JC; Santantonio BM; Chang YC; Best CA; Reinhardt JW; Blum KM; Yi T; Breuer CK
    Adv Healthc Mater; 2020 Dec; 9(24):e2001094. PubMed ID: 33073543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tissue-engineered vascular grafts form neovessels that arise from regeneration of the adjacent blood vessel.
    Hibino N; Villalona G; Pietris N; Duncan DR; Schoffner A; Roh JD; Yi T; Dobrucki LW; Mejias D; Sawh-Martinez R; Harrington JK; Sinusas A; Krause DS; Kyriakides T; Saltzman WM; Pober JS; Shin'oka T; Breuer CK
    FASEB J; 2011 Aug; 25(8):2731-9. PubMed ID: 21566209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implanted Tissue-Engineered Vascular Graft Cell Isolation with Single-Cell RNA Sequencing Analysis.
    Mirhaidari GJM; Barker JC; Breuer CK; Reinhardt JW
    Tissue Eng Part C Methods; 2023 Feb; 29(2):72-84. PubMed ID: 36719780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of small diameter nanofiber tissue engineered arterial grafts.
    Kurobe H; Maxfield MW; Tara S; Rocco KA; Bagi PS; Yi T; Udelsman B; Zhuang ZW; Cleary M; Iwakiri Y; Breuer CK; Shinoka T
    PLoS One; 2015; 10(4):e0120328. PubMed ID: 25830942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel Association of miR-451 with the Incidence of TEVG Stenosis in a Murine Model.
    Hibino N; Best CA; Engle A; Ghimbovschi S; Knoblach S; Nath DS; Ishibashi N; Jonas RA
    Tissue Eng Part A; 2016 Jan; 22(1-2):75-82. PubMed ID: 26573748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeted imaging of matrix metalloproteinase activity in the evaluation of remodeling tissue-engineered vascular grafts implanted in a growing lamb model.
    Stacy MR; Naito Y; Maxfield MW; Kurobe H; Tara S; Chan C; Rocco KA; Shinoka T; Sinusas AJ; Breuer CK
    J Thorac Cardiovasc Surg; 2014 Nov; 148(5):2227-33. PubMed ID: 24952823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The innate immune system contributes to tissue-engineered vascular graft performance.
    Hibino N; Mejias D; Pietris N; Dean E; Yi T; Best C; Shinoka T; Breuer C
    FASEB J; 2015 Jun; 29(6):2431-8. PubMed ID: 25713026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pericyte-based human tissue engineered vascular grafts.
    He W; Nieponice A; Soletti L; Hong Y; Gharaibeh B; Crisan M; Usas A; Peault B; Huard J; Wagner WR; Vorp DA
    Biomaterials; 2010 Nov; 31(32):8235-44. PubMed ID: 20684982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implantation of inferior vena cava interposition graft in mouse model.
    Lee YU; Yi T; Tara S; Lee AY; Hibino N; Shinoka T; Breuer CK
    J Vis Exp; 2014 Jun; (88):. PubMed ID: 24961688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.